In-vitro activity of cefoxitin against recent clinical bacterial isolates

Area of Science:

• Clinical microbiology
• Antimicrobial susceptibility testing

Background:

• Cefoxitin is a key antibiotic for treating infections.
• Understanding bacterial resistance patterns is crucial for effective treatment.

Purpose of the Study:

• To determine the susceptibility of clinical bacterial isolates to cefoxitin.
• To identify variations in cefoxitin sensitivity across different infection sources.

Main Methods:

• Susceptibility testing of 635 clinical bacterial isolates to cefoxitin.
• Categorization of isolates based on origin: urinary tract, infected wounds, blood cultures, and heart valve homografts.

Main Results:

• High cefoxitin sensitivity observed in urinary tract (97%) and infected wound (93%) isolates.
• Lower sensitivity in blood culture (82%) and heart valve homograft (71%) isolates.
• Predominant resistance in Pseudomonas species and low sensitivity (50%) in Streptococcus faecalis.

Conclusions:

• Cefoxitin demonstrates variable efficacy depending on bacterial species and infection site.
• Pseudomonas and Streptococcus faecalis represent significant challenges for cefoxitin therapy.
• Further investigation into antimicrobial resistance patterns is warranted for optimizing treatment strategies.